October 2021

Digitsole Pro for Clinical Assessment of Mobility Disorders

Digitsole Pro® is an FDA-approved Class II device developed with, and for, healthcare professionals to improve the clinical assessment of patients with mobility disorders. This assessment advancement measures objective biomechanical data not observable by the naked eye, which can be used to help improve a patient’s walking or running, and advance recovery from neurological, orthopedic, and age- or sport-related conditions. Each insole has an inertial platform that records the walking steps, running strides, and orientations of a foot in space. The proprietary artificial intelligence algorithms process this data to calculate the spatiotemporal, kinematic, and advanced parameters displayed in the digital interface. The connected chips inserted into a patient’s insoles send the data collected at the end of each activity. The biomechanical results of the analysis are clearly understandable and are available within a few minutes for practical application.


Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.